News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Dee Sparacio: We hope you can join us for the gynecologic cancer chat
Photos of Nita Lee, Dee Sparacio, Shannon Westin, Christina Lizaso
Jun 12, 2024, 14:09

Dee Sparacio: We hope you can join us for the gynecologic cancer chat

Dee Sparacio, Ovarian Cancer Survivor, Author and Research Advocate, shared on X:

“We hope you can join Christina Lizaso, Shannon Westin, and Nita Lee and I on Wed 6/12 at 8pm ET for the gynecologic cancer chat.”

Dee Sparacio

Source: Dee Sparacio/X

cancer Christina Lizaso Dee Sparacio Gynecologic Cancer Nita Lee OncoDaily Oncology Shannon Westin
Special Coverage
Career
Dec 31, 2024, 04:43
OncoInfluencers to Follow on Social Media: Jasmina Koeva
Positive
Dec 31, 2024, 03:42
Improving the lives of children with cancer everywhere - St. Jude Children's Research Hospital
Blog
Dec 31, 2024, 03:37
Matthew Pech: The failure of ex vivo gene therapy for sickle cell and the role of the TPP in the drug development process
Science
Dec 31, 2024, 03:34
Cristian Ochoa Arnedo: Empowerment among breast cancer survivors using an online peer support community
Blog
Dec 30, 2024, 19:52
CelloType: A New Machine Learning Tool for Analyzing Cancer Cells and Tissues
Blog
Dec 30, 2024, 19:26
“QI Scholar Nursing Presentations Part 2” from the SIOP Nursing Network
Science
Dec 30, 2024, 13:52
Nico Gagelmann: Selected clinical studies 2024 in hematology
Insight
Dec 30, 2024, 13:43
Roupen Odabashian: When it comes to real-life cases, physicians still outperform AI
Blog
Dec 30, 2024, 13:42
Shaban Juma: The key to being one step ahead in the fight against cancer
Insight
Dec 30, 2024, 13:35
James Crowley: Elevated expression of CCR7 is generally indicative of poor prognosis in cancers
Insight
Dec 30, 2024, 13:30
Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer
Blog
Dec 30, 2024, 13:25
Sanjay Popat: Wouldn’t it be great if FDA Oncology approvals were mutually approvable by MHRA?